Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03110003 · ClinicalTrials.gov registry record · Phase 3
Bupivacaine With Epidural Volume Extension
A Phase 3 study, sponsored by University of Alabama at Birmingham.
- Completed
- Registry status
- Phase 3
- Development phase
- 45
- Enrollment target
NCT03110003: Completed Phase 3 study, sponsored by University of Alabama at Birmingham.
NCT03110003 is a Phase 3 study that has completed, run by University of Alabama at Birmingham. The registered enrollment target is 45 participants, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03110003, a Phase 3 study, has completed, sponsored by University of Alabama at Birmingham.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 45 participants
- Enrollment target
Study Summary
In this study the investigator will address the efficacy of using low dose bupivacaine spinal anesthesia (SA) in combination with epidural volume extension (EVE) for patients undergoing short obstetric procedures.
Primary Outcome
Time from entrance into the PACU until PACU discharge criteria met
Interventions
- DRUG 10 mg Bupivacaine
- DRUG 5 mg Bupivacaine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 45 participants |
| Start Date | 2016-06-27 |
| Est. Completion | 2018-09-30 |
| Phase | Phase 3 |
What the finished NCT03110003 record still lists
NCT03110003 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 45 participants, a relatively small participant target, below the 772-participant average among 15,282 other Phase 3 trials with a reported enrollment target (94% lower).
The record links to 0 conditions, and to 2 interventions - of which 10 mg Bupivacaine is the first listed.
NCT03110003 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT03110003 about?
NCT03110003 is a clinical study titled "Bupivacaine With Epidural Volume Extension". In this study the investigator will address the efficacy of using low dose bupivacaine spinal anesthesia (SA) in combination with epidural volume extension (EVE) for patients undergoing short obstetric procedures.
What is the current status of trial NCT03110003?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 45 participants. The study started on 2016-06-27. Estimated completion is 2018-09-30.
What interventions are being tested in trial NCT03110003?
The interventions under investigation include: 10 mg Bupivacaine (DRUG), 5 mg Bupivacaine (DRUG).
Who is sponsoring clinical trial NCT03110003?
This trial is sponsored by University of Alabama at Birmingham, which has 1,160 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT03110003's enrollment target sits among peer trials
45 1870th of 2000 higher than 127 of 2,000 other Phase 3 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 3 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00804154 · 45 participants · Phase 1
Resiniferatoxin to Treat Severe Pain Associated With Advanced Cancer
- NCT01851694 · 45 participants · NA
Beta-cell Response to Incretin Hormones in Cystic Fibrosis
- NCT02896335 · 45 participants · Phase 2
Palbociclib and Pembrolizumab In Central Nervous System Metastases
- NCT03454035 · 45 participants · Phase 1
Ulixertinib/Palbociclib in Patients With Advanced Pancreatic and Other Solid Tumors
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI